The fight against cancer just got personal. Top docs and thinkers explain how genetic medicine is going to change how we fight the disease.
June 7, 2017
Pharmaceutical company Merck made history last month. The approval of its product Keytruda marked the first time that the Food and Drug Administration will allow a drug to be prescribed based on a cancer patient’s genetic profile rather than tumor location.